The Impact of COVID‐19 on the Initiation of Clinical Trials in Europe and the United States-Reference-Cited by-同舟云学术

The Impact of COVID‐19 on the Initiation of Clinical Trials in Europe and the United States

Author:

Lasch Florian¹²,Psarelli Eftychia‐Eirini¹³,Herold Ralf¹,Mattsson Andrea¹⁴,Guizzaro Lorenzo¹⁵,Pétavy Frank¹,Schiel Anja⁶⁷

Affiliation:

1. European Medicines Agency Amsterdam The Netherlands

2. Hannover Medical School Hannover Germany

3. Liverpool Clinical Trials Centre University of Liverpool Liverpool UK

4. Mathematical Statistics Faculty of Science Lund University Lund Sweden

5. Universitá della Campania Luigi Vanvitelli Statistica Medica Napoli Italy

6. Regulatory and Pharmacoeconomic Statistics Norwegian Medicines Agency (NoMA) Norway

7. Chair of Scientific Advice Working Party (SAWP) European Medicines Agency Amsterdam The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference36 articles.

1. Medidata(2020).COVID‐19 and clinical trials: the Medidata perspective (2020).

2. National Institute of Health(2020 November 4).Continued Impact of COVID‐19 on Biomedical Research. Accessed October 28 2021.

5. The impact of COVID‐19 on the clinical trial;Chen Z.;PLoS One,2021

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献